2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Prostate Biopsy
Prostate biopsy, a cornerstone of cancer diagnosis, involves the removal of tissue samples from the prostate gland to detect cancerous cells. Typically conducted when other tests, like PSA screening or digital rectal exams, suggest abnormalities, it's vital for accurate diagnosis and treatment planning. Utilizing imaging guidance, such as ultrasound, doctors precisely target suspicious areas for sampling, often using a needle to extract tissue. While effective, biopsies carry risks, including bleeding and infection, highlighting the need for careful patient monitoring post-procedure. Innovations like MRI-guided biopsies enhance accuracy, reducing unnecessary procedures and improving cancer detection rates. Moreover, ongoing research focuses on refining biopsy techniques, exploring biomarkers, and developing non-invasive alternatives, promising more precise and patient-friendly diagnostic approaches in the future.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China